王琰，女，博士，研究员，博士生导师，太阳集团1088vip药物代谢室副主任，“创新药物非临床药物代谢及PK/PD研究”北京市重点实验室主任，现任中国药理学会药物代谢专委会副主任委员（兼秘书长）、中国药理学会精准分析药理学专委会常委、北京药理学会药物代谢专委会主任委员、北京药理学会常务理事等，以及《药学学报》及Acta Pharm Sin B.、《中国药学杂志》、《药物分析杂志》、《中草药》等编委。
她长期从事药物代谢转化、药代动力学以及肠道菌药物药理学等研究，突出贡献是她应用多组学技术创新建立了天然药物（难吸收）与肠道菌相互作用的关键技术并用于实践，阐明了多个天然药物（小檗碱、巴戟天寡糖、芍药内脂苷等）在肠道菌作用下的化学基础及生物学原理。她牵头（负责）50余项课题，参加 6 项新药研制，申请及授权专利 14 项，发表论文110+篇，如Signal Transduct Target Ther，Acta Pharm Sin B.，Theranostics，Engineering，Metabolism等SCI期刊论文，最高影响因子>38，这些成果对肠道菌药物研究产生重要影响。

王琰研究员的方向是药物代谢、药动学与药物分析研究，主要围绕以下几个方面开展：1）肠道菌与天然药物相互作用关键技术研究及运用；2）天然药物及天然活性成分代谢转化及药代动力学；3）用于结直肠癌早期诊断的多肽探针体内代谢及关键技术研发。她的研究聚焦在天然药物与肠道菌相互作用及分子机制领域，先后发现了小檗碱通过肠道菌NR酶调节血脂的分子机制及个性化治疗，以及药物刺激肠道菌产生丁酸协同发挥降血脂机制。同时，也发现口服小檗碱可诱导肠道菌合成多巴而增加脑中多巴胺水平改善帕金森氏症，以及芍药活性成分被肠道菌CE酶转化的代谢产物通过“肠-脑”通路而改善抑郁的分子机制。这些研究在肠道菌药学研究领域有重要影响力。

1. Shu-Rong Ma#, Qian Tong#, Yuan Lin#, Li-Bin Pan#, Jie Fu#, Ran Peng, Xian-Feng Zhang, Zhen-Xiong Zhao, Yang Li, Jin-Bo Yu, Lin Cong, Pei Han, Zheng-Wei Zhang, Hang Yu, Yan Wang* and Jian-Dong Jiang*. Berberine treats atherosclerosis via a vitamine-like effect down-regulating Choline-TMA-TMAO production pathway in gut microbiota [J]. Signal Transduction and Targeted Therapy. 2022, 7:207.
2. Yan Wang#*, Qian Tong#, Shu-Rong Ma#, Zhen-Xiong Zhao#, Li-Bin Pan , Lin Cong, Pei Han, Ran Peng, Hang Yu, Yuan Lin, Tian-Le Gao, Jia-Wen Shou, Xiao-Yang Li, Xian-Feng Zhang, Zheng-Wei Zhang, Jie Fu, Bao-Ying Wen, Jin-Bo Yu, Xuetao Cao* and Jian-Dong Jiang*. Oral berberine improves brain dopa/dopamine levels to ameliorate Parkinson’s disease by regulating gut microbiota [J]. Signal Transduction and Targeted Therapy. 2021, 24;6(1):1-20.
3. Li-Bin Pan#, Hang Yu#, Jie Fu#, Jia-Chun Hu, Hui Xu, Zheng-Wei Zhang, Meng-Meng Bu, Xin-Yu Yang, Hao-Jian Zhang, Jin-Yue Lu, Jian-Dong Jiang* and Yan Wang*. Berberine ameliorates chronic kidney disease through inhibiting the production of gut-derived uremic toxins in the gut microbiota [J]. Acta Pharmaceutica Sinica B. 2023;13(4):1537-1553.
4. Xin-Yu Yang#, Hang Yu#, Jie Fu#, Hui-Hui Guo, Pei Han, Shu-Rong Ma, Li-Bin Pan, Zheng-Wei Zhang, Hui Xu, Jia-Chun Hu, Hao-Jian Zhang, Meng-Meng Bu, Xian-Feng Zhang, Wei Yang, Jing-Yue Wang, Jing-Yu Jin, Hui-Cong Zhang, Dong-Rui Li, Jin-Yue Lu, Yuan Lin*, Jian-Dong Jiang*, Qian Tong* and Yan Wang*. Hydroxyurea ameliorates atherosclerosis in ApoE -/- mice by potentially modulating Niemann-Pick C1-like 1 protein through the gut microbiota [J]. Theranostics, 2022, 12(18): 7775-7787.
5. Zheng-Wei Zhang#, Chun-Sheng Gao#, Heng Zhang#, Jian Yang, Ya-Ping Wang, Li-Bin, Pan, Hang Yu, Chi-Yu He, Hai-Bin Luo, Zhen-Xiong Zhao, Xin-Bo Zhou, Yu-Li Wang, Jie Fu, Pei Han, Yu-hui Dong, Gang Wang, Song Li*, Yan Wang*, Jian-Dong Jiang* and Wu Zhong*. Morinda officinalis oligosaccharides increase serotonin in the brain and ameliorate depression via promoting 5-hydroxytryptophan production in the gut microbiota [J]. Acta Pharmaceutica Sinica B. 2022, 12(8):3298-3312.
6. Zheng-Wei Zhang#, Lin Cong#, Ran Peng, Pei Han, Shu-Rong Ma, Li-Bin Pan, Jie Fu, Hang Yu, Yan Wang* and Jian-Dong Jiang*. Transformation of Berberine to Its Demethylated Metabolites by the CYP51 Enzyme in the Gut Microbiota [J]. Journal of Pharmaceutical Analysis. 2021, 11(5):628-637.
7. Han P, Li LS, Wang ZX, Xi L, Yu H, Cong L, Zhang ZW, Fu J, Peng R, Pan LB, Ma SR. Wang XY, Wang HT*, Wang Y*, Sun JL*, Jiang JD*. Multi-Omics Analysis Provides Insight into the Possible Molecular Mechanism of Hay Fever Based on Gut Microbiota. Engineering. 2021; 15: 115-125.
8. Shang J, Ma S, Zang CX, Bao XQ*, Wang Y*, Zhang D*. Gut microbiota mediates the absorption of FLZ, a new drug for Parkinson’s disease treatment. Acta Pharmaceutica Sinica B. 2021 May;11(5):1213-1226.
9. Pan L, Han P, Ma S, Peng R, Wang C, Kong W, Cong L, Fu J, Zhang Z, Yu H, Wang Y*, Jiang J.D*. Abnormal metabolism of gut microbiota reveals the possible molecular mechanism of nephropathy induced by hyperuricemia. Acta Pharmaceutica Sinica B. 2020 Feb;10(2):249-261.
10. Zhen-Xiong Zhao, Jie Fu, Shu-Rong Ma, Ran Peng, Jin-Bo Yu, Lin Cong, Li-Bin Pan, Zuo-Guang Zhang, Hui Tian, Chun-Tao Che, Yan Wang*, Jian-Dong Jiang*. Gut-brain axis metabolic pathway regulates antidepressant efficacy of albiflorin. Theranostics. 2018 Nov 13;8(21):5945-5959.
11. Yan Wang*, Qian Tong, Jia-Wen Shou, Zhen-Xiong Zhao, Xiao-Yang Li, Xian-Feng Zhang, Shu-Rong Ma, Chi-Yu He, Bao-Ying Wen, Fang Guo, Jie Fu, Jian-Dong Jiang*. Gut microbiota-mediated personalized treatment of hyperlipidemia using berberine. Theranostics, 2017 June, 7(9): 2443-2451.
12. Yan Wang*, Jia-Wen Shou, Xiao-Yang Li, Zhen-Xiong Zhao, Jie Fu, Chi-Yu He, Ru Feng, Chao Ma, Bao-Ying Wen, Fang Guo, Xin-Yi Yang, Yan-Xing Han, Lu-Lu Wang, Qian Tong, Xue-Fu You, Yuan Lin, Wei-Jia Kong, Shu-Yi Si, Jian-Dong Jiang*. Berberine-induced bioactive metabolites of gut microbiota improves energy metabolism. Metabolism-clinical & Experimental, 2017 May, 70, 72–84.
13. Hang Yu, Baoying Wen, Min Huang, Ru Feng, Libin Pan, Manyi Xu, Hao Lin, Lin Cong, Sen Zhang, Yan Li, Chi-Hin Cho, Chongjing Zhang, Xiaoguang Chen, Yan Wang*. TCP-1, a novel peptide to diagnose early colon cancer. Chinese Chemical Letters, Available online 19 February 2023, https://doi.org/10.1016/j.cclet.2023.108235
14. Hui Xu #, Hang Yu #, Jie Fu, Zheng-Wei Zhang, Jia-Chun Hu, Jin-Yue Lu, Xin-Yu Yang, Meng-Meng Bu, Jian-Dong Jiang* and Yan Wang*. Metabolites analysis of plantamajoside based on gut microbiota-drug interaction [J]. Phytomedicine, 2023, 116:154841.
15. Hang Yu#, Hui Xu#, Xinyu Yang, Zhengwei Zhang, Jiachun Hu, Jinyue Lu, Jie Fu, Mengmeng Bu, Haojian Zhang, Zhao Zhai, Jingyue Wang, Jiandong Jiang*, Yan Wang*. Gut microbiota-based PK-PD study and molecular mechanism of Specnuezhenide in the treatment of colorectal cancer targeting carboxylesterase. J Pharm Anal. 2023. Accepted. Doi: 10.1016/j.jpha.2023.06.012

1. 《肠道菌与药物代谢》，主编，科学出版社，2022年。
2. 《小檗碱》，编委，科学出版社，2018年
3. 《The Chemistry and Biological Activities of (-)-Clasenamide》, 副主编，化学工业出版社，2014
4. 《中草药现代研究》，编委，中国协和医科大学出版社, 2010年